Partnering Opportunities
Partnering Opportunities
Affibodys partnering strategy is to engage in partnerships centered around:
- Target-by-target development of novel biotherapeutics (discovery collaborations), or
- Out-licensing of Albumod™ technology
For opportunities for collaborative, partnership or licensing agreements, please contact bd@affibody.com.
Affibodys latest Press releases
2022-11-08
Affibody in short
Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.
Upcoming reports Financial calendar
- Interim Report January to March 2020 (May 15, 2020)
- Interim Report January to June 2020 (August 21, 2020)
- Interim Report January to September 2020 (November 13, 2020)
- Year End Report 2020 (February 2021)